Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
Manage episode 355227657 series 3381434
Tekijältä ReachMD. Player FM:n ja yhteisömme löytämä — tekijänoikeuksien omistajana on kustantaja eikä Player FM ja ääntä lähetetään suoraan heidän palvelimiltaan. Napsauta Tilaa -painiketta, kun haluat seurata Player FM:n päivityksiä tai liittää syötteen URL-osoitteen muihin podcast-sovelluksiin.
CME credits: 0.25
Valid until: 13-02-2024
Claim your CME credit at https://reachmd.com/programs/cme/recent-advances-and-emerging-approaches-in-the-treatment-of-recurrentmetastatic-scchn-matching-the-patient-to-the-optimal-therapy/14495/
While key clinical trials inform our management philosophy for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), the paucity of predictive markers, limited guidance to treatment sequencing, and inherent therapeutic toxicity provide challenges for both clinicians and patients. How can we best stratify our patients to ensure the most optimal outcomes? Join Drs. Ezra Cohen and Petr Szturz as they offer cogent answers to the difficult questions you face in your daily medical practice.=
…
continue reading
Valid until: 13-02-2024
Claim your CME credit at https://reachmd.com/programs/cme/recent-advances-and-emerging-approaches-in-the-treatment-of-recurrentmetastatic-scchn-matching-the-patient-to-the-optimal-therapy/14495/
While key clinical trials inform our management philosophy for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), the paucity of predictive markers, limited guidance to treatment sequencing, and inherent therapeutic toxicity provide challenges for both clinicians and patients. How can we best stratify our patients to ensure the most optimal outcomes? Join Drs. Ezra Cohen and Petr Szturz as they offer cogent answers to the difficult questions you face in your daily medical practice.=
983 jaksoa
Jaa
))
